US Bancorp’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$622K Buy
14,866
+12,493
+526% +$484K ﹤0.01% 1442
2026
Q1
$89.4K Sell
2,373
-60
-2% -$1.96K ﹤0.01% 2440
2025
Q4
$73.2K Buy
2,433
+34
+1% +$962 ﹤0.01% 2515
2025
Q3
$62.9K Buy
2,399
+26
+1% +$620 ﹤0.01% 2562
2025
Q2
$50.6K Buy
+2,373
New +$53.5K ﹤0.01% 2783

Other funds holding GRDN

US Bancorp's GRDN Position: Q2 2026 in Review

US Bancorp increased its Guardian Pharmacy Services (GRDN) stake by 526% in Q2 2026, buying an estimated $484K and bringing the position to 14,866 shares worth $622K. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

US Bancorp first reported a position in GRDN in Q2 2025 and has held it in 5 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • US Bancorp held 14,866 shares of Guardian Pharmacy Services worth $622K as of Q2 2026.
  • US Bancorp bought 12,493 Guardian Pharmacy Services shares in Q2 2026, an estimated $484K.
  • Guardian Pharmacy Services made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1442 holding.
  • US Bancorp first reported a position in Guardian Pharmacy Services in Q2 2025 and has held it in 5 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.